List of Charts
Chart 1.1: Peripheral Vascular Device Market by Segment, Europe, 2022 - 2029
Chart 1.2: Peripheral Vascular Device Market Overview, Europe, 2022 & 2029
Chart 2.1: Multi-Scenario Peripheral Vascular Device Market Forecast, Europe, 2019 - 2029 (€M)
Chart 5.1: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029
Chart 5.2: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022
Chart 6.1: Country Profile, Germany, 2022
Chart 6.2: Country Profile, France, 2022
Chart 6.3: Country Profile, United Kingdom, 2022
Chart 6.4: Country Profile, Italy, 2022
Chart 6.5: Country Profile, Spain, 2022
Chart 6.6: Country Profile, Benelux, 2022
Chart 6.7: Country Profile, Scandinavia, 2022
Chart 6.8: Country Profile, Austria, 2022
Chart 6.9: Country Profile, Switzerland, 2022
Chart 6.10: Country Profile, Portugal, 2022
Chart 7.1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029
Chart 8.1: Peripheral Vascular Stent Market by Segment, Europe, 2019 - 2029
Chart 8.2: Leading Competitors, Peripheral Vascular Stent Market, Europe, 2022
Chart 9.1: Pta Balloon Catheter Market by Segment, Europe, 2019 - 2029
Chart 9.2: Leading Competitors, Pta Balloon Catheter Market, Europe, 2022
Chart 10.1: Drug-Coated Balloon Market, Europe, 2019 - 2029
Chart 10.2: Leading Competitors, Drug-Coated Balloon Market, Europe, 2022
Chart 11.1: Atherectomy Device Market by Segment, Europe, 2019 - 2029
Chart 11.2: Leading Competitors, Atherectomy Device Market, Europe, 2022
Chart 12.1: Intravascular Lithotripsy Market by Segment, Europe, 2019 - 2029
Chart 13.1: Cto Device Market by Segment, Europe, 2019 - 2029
Chart 13.2: Leading Competitors, Cto Device Market, Europe, 2022
Chart 14.1: Surgical Graft Market by Segment, Europe, 2019 - 2029
Chart 14.2: Leading Competitors, Surgical Graft Market, Europe, 2022
Chart 15.1: Stent Graft Market by Segment, Europe, 2019 - 2029
Chart 15.2: Leading Competitors, Stent Graft Market, Europe, 2022
Chart 16.1: Embolic Protection Device Market by Segment, Europe, 2019 - 2029
Chart 16.2: Leading Competitors, Embolic Protection Device Market, Europe, 2022
Chart 17.1: Peripheral Thrombus Management Market by Segment, Europe, 2019 - 2029
Chart 17.2: Leading Competitors, Peripheral Thrombus Management Market, Europe, 2022
Chart 18.1: Inferior Vena Cava Filter Market by Segment, Europe, 2019 - 2029
Chart 18.2: Leading Competitors, Inferior Vena Cava Filter Market, Europe, 2022
Chart 19.1: Carotid Shunt Market, Europe, 2019 - 2029
Chart 19.2: Leading Competitors, Carotid Shunt Market, Europe, 2022
Chart 20.1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2019 - 2029
Chart 20.2: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2022
Chart 21.1: Diagnostic and Interventional Guidewire Market by Segment, Europe, 2019 - 2029
Chart 21.2: Leading Competitors, Diagnostic and Interventional Guidewire Market, Europe, 2022
Chart 22.1: Introducer Sheath Market by Segment, Europe, 2019 - 2029
Chart 22.2: Leading Competitors, Introducer Sheath Market, Europe, 2022
Chart 23.1: Vascular Closure Device Market by Segment, Europe, 2019 - 2029
Chart 23.2: Leading Competitors, Vascular Closure Device Market, Europe, 2022
Chart 24.1: Transcatheter Embolization Market by Segment, Europe, 2019 - 2029
Chart 24.2: Leading Competitors, Transcatheter Embolization Market, Europe, 2022
Chart 25.1: Peripheral Ivus Market, Europe, 2019 - 2029
Chart 25.2: Leading Competitors, Peripheral Ivus Market, Europe, 2022
List of Figures
Figure 1.1: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (1 of 4)
Figure 1.2: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (2 of 4)
Figure 1.3: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (3 of 4)
Figure 1.4: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (4 of 4)
Figure 1.5: Companies Researched in this Report
Figure 1.6: Factors Impacting the Peripheral Market by Segment, Europe (1 of 4)
Figure 1.7: Factors Impacting the Peripheral Market by Segment, Europe (2 of 4)
Figure 1.8: Factors Impacting the Peripheral Market by Segment, Europe (3 of 4)
Figure 1.9: Factors Impacting the Peripheral Market by Segment, Europe (4 of 4)
Figure 1.10: Recent Events in the Peripheral Vascular Device Market, Europe, 2019 - 2023
Figure 1.11: Peripheral Vascular Device Procedures Covered, Europe (1 of 3)
Figure 1.12: Peripheral Vascular Device Procedures Covered, Europe (2 of 3)
Figure 1.13: Peripheral Vascular Device Procedures Covered, Europe (3 of 3)
Figure 1.14: Peripheral Vascular Device Markets Covered, Europe (1 of 3)
Figure 1.15: Peripheral Vascular Device Markets Covered, Europe (2 of 3)
Figure 1.16: Peripheral Vascular Device Markets Covered, Europe (3 of 3)
Figure 1.17: Key Report Updates
Figure 1.18: Version History
Figure 2.1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 - 2029 (€M) (1 of 2)
Figure 2.2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 - 2029 (€M) (2 of 2)
Figure 2.3: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 - 2029 (€M) (1 of 2)
Figure 2.4: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 - 2029 (€M) (2 of 2)
Figure 2.5: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 - 2029 (€M) (1 of 2)
Figure 2.6: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 - 2029 (€M) (2 of 2)
Figure 4.1: Peripheral Vascular Stent by Company (1 of 2)
Figure 4.2: Peripheral Vascular Stent by Company (2 of 2)
Figure 4.3: Pta Balloon Catheter by Company (1 of 3)
Figure 4.4: Pta Balloon Catheter by Company (2 of 3)
Figure 4.5: Pta Balloon Catheter by Company (3 of 3)
Figure 4.6: Drug-Coated Balloon by Company
Figure 4.7: Atherectomy Device by Company (1 of 2)
Figure 4.8: Atherectomy Device by Company (2 of 2)
Figure 4.9: Lithotripsy Device by Company
Figure 4.10: Chronic Total Occlusion Device by Company
Figure 4.11: Surgical Graft by Company (1 of 2)
Figure 4.12: Surgical Graft by Company (2 of 2)
Figure 4.13: Stent Graft by Company
Figure 4.14: Embolic Protection Device by Company
Figure 4.15: Peripheral Thrombus Management by Company
Figure 4.16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2)
Figure 4.17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2)
Figure 4.18: Carotid Shunt by Company
Figure 4.19: Diagnostic and Interventional Catheters by Company (1 of 2)
Figure 4.20: Diagnostic and Interventional Catheters by Company (2 of 2)
Figure 4.21: Diagnostic and Interventional Guidewire by Company (1 of 3)
Figure 4.22: Diagnostic and Interventional Guidewire by Company (2 of 3)
Figure 4.23: Diagnostic and Interventional Guidewire by Company (3 of 3)
Figure 4.24: Introducer Sheath by Company (1 of 2)
Figure 4.25: Introducer Sheath by Company (2 of 2)
Figure 4.26: Vascular Closure Device by Company
Figure 4.27: Transcatheter Embolization Devices by Company (1 of 2)
Figure 4.28: Transcatheter Embolization Devices by Company (2 of 2)
Figure 4.29: Peripheral Ivus Catheter by Company
Figure 4.30: Class 2 Device Recall Venovo Venous Stent System
Figure 4.31: Class 1 Device Recall Vici Venous Stent System
Figure 4.32: Class 2 Device Recall Eluvia
Figure 4.33: Class 2 Device Recall Palmaz Genesis
Figure 4.34: Class 2 Device Recall S.M.A.R.T. Flex
Figure 4.35: Class 1 Device Recall Precise Pro Rx Carotid Stent Implant System
Figure 4.36: Class 2 Device Recall Cordis S.M.A.R.T. Control /S.M.A.R.T. Vascular Stent System
Figure 4.37: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
Figure 4.38: Class 2 Device Recall Cordis Precise Nitinol Stent System
Figure 4.39: Class 2 Device Recall Formula 418 Renal Balloonexpandable Stent
Figure 4.40: Class 2 Device Recall Zilver 635 Biliary Stent
Figure 4.41: Class 2 Device Recall Zilver 518 Biliary Stent
Figure 4.42: Class 1 Device Recall Atrium
Figure 4.43: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent
Figure 4.44: Class 2 Device Recall Medtronic Abre
Figure 4.45: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System
Figure 4.46: Class 2 Device Recall Enroute Transcarotid Stent System
Figure 4.47: Class 2 Device Recall Gore Viabahn Vbx, Balloon Expandable Endoprosthesis
Figure 4.48: Class 2 Device Recall Conquest Pta Balloon Dilatation Catheter
Figure 4.49: Class 2 Device Recall Conquest 40 Pta Dilatation Catheter
Figure 4.50: Class 2 Device Recall Cordis Saber Pta Balloon Dilation Catheter
Figure 4.51: Class 2 Device Recall Cordis Powerflex P3, Pta Dilation Catheter
Figure 4.52: Class 2 Device Recall Cordis Maxi Ld Pta Dilatation Catheter
Figure 4.53: Class 2 Device Recall Powerflex Pro Percutaneous Transluminal Angioplasty (Pta) Catheter
Figure 4.54: Class 1 Device Recall Advance Enforcer 35 Focal Force Pta Balloon Catheter
Figure 4.55: Class 2 Device Recall Medtronic In.Pact Admiral, Paclitaxelcoated Pta Balloon Catheter
Figure 4.56: Class 2 Device Recall Chameleon Pta Balloon Dilation Catheter
Figure 4.57: Class 2 Device Recall Boston Scientific Rotapro
Figure 4.58: Class 2 Device Recall Stealth 360 Gen2 Peripheral Orbital Atherectomy System
Figure 4.59: Class 2 Device Recall Diamondback 360 Gen2 Peripheral Orbital Atherectomy System
Figure 4.60: Class 1 Device Recall Turbohawk Plus
Figure 4.61: Class 1 Device Recall Hawkone
Figure 4.62: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (Ivl) System
Figure 4.63: Class 1 Device Recall Intraclude Intraaortic Occlusion Device
Figure 4.64: Class 2 Device Recall Intergard Woven Vascular Graft
Figure 4.65: Class 2 Device Recall Interavascular Sas/Getinge
Figure 4.66: Class 2 Device Recall Hemashield Gold Knitted Bifurcated
Figure 4.67: Class 2 Device Recall Atrium Advanta Vxt Vascular Graft
Figure 4.68: Class 2 Device Recall Hemashield Microvel Double Velour Knitted Vascular Grafts
Figure 4.69: Class 2 Device Recall Hemashield Platinum Woven/Microvel Double Velour Vascular Grafts
Figure 4.70: Class 2 Device Recall Hemashield Platinum Woven Double Velour Vascular Graft
Figure 4.71: Class 2 Device Recall Vascutek/Terumo
Figure 4.72: Class 2 Device Recall Gore Propaten Vascular Graft
Figure 4.73: Class 1 Device Recall Endologix Afx2 Bifurcated Endograft System
Figure 4.74: Class 1 Device Recall Endologix Afx/Afx2, Proximal (Aortic) Extension Endograft
Figure 4.75: Class 1 Device Recall Endologix Afx Endovascular Aaa System
Figure 4.76: Class 1 Device Recall Endologix Afx/Afx2, Limb (Iliac) Extension Endograft
Figure 4.77: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
Figure 4.78: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
Figure 4.79: Class 2 Device Recall Zenith Alpha Spiralz Endovascular Leg
Figure 4.80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
Figure 4.81: Class 2 Device Recall Endurant, Endurant Ii and Endurant Iis Stent Graft Systems
Figure 4.82: Class 2 Device Recall Endurant Stent Graft System
Figure 4.83: Class 2 Device Recall Endurant Ii Stent Graft System
Figure 4.84: Class 2 Device Recall Endurant Ii/Iis Stent Graft System
Figure 4.85: Class 2 Device Recall Endurant Ii/Iis Stent Graft System
Figure 4.86: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System
Figure 4.87: Class 2 Device Recall Ekos
Figure 4.88: Class 2 Device Recall Ekosonic Endovascular Device
Figure 4.89: Class 2 Device Recall Ekos Control System
Figure 4.90: Class 2 Device Recall Angiojet Ultra Consoles Thrombectomy System
Figure 4.91: Class 1 Device Recall Arrowtrerotola Ptd
Figure 4.92: Class 1 Device Recall Arrowtrerotola Percutaneous Thrombolytic Device
Figure 4.93: Class 1 Device Recall Arrowtrerotola Overthewire Ptd Kit Percutaneous Thrombolytic Device: 7Fr
Figure 4.94: Device Recall Angiojet Ultra 5000 a Console, Boston Scientific
Figure 4.95: Class 3 Device Recall Cook
Figure 4.96: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set
Figure 4.97: Class 2 Device Recall Softvu Omni Flush Angiographic Catheter
Figure 4.98: Class 2 Device Recall Seeker(R) Crossing Support Catheter
Figure 4.99: Class 1 Device Recall Imager Ii 5F Angiographic Catheter
Figure 4.100: Class 1 Device Recall Super Torque Mb 5F Pig
Figure 4.101: Class 1 Device Recall Crosscath Support Catheter
Figure 4.102: Class 2 Device Recall Torcon Nb Advantage
Figure 4.103: Class 2 Device Recall Amplatz Extra Stiff Wire Guide
Figure 4.104: Class 2 Device Recall Bentson Wire Guide
Figure 4.105: Class 2 Device Recall Cope Mandril Wire Guide
Figure 4.106: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol)
Figure 4.107: Class 2 Device Recall Coons Interventional Wire Guide
Figure 4.108: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
Figure 4.109: Class 2 Device Recall Newton Wire Guide
Figure 4.110: Class 2 Device Recall Roadrunner Pc Hydrophilic Wire Guide
Figure 4.111: Class 2 Device Recall Roadrunner Pc Wire Guide (Nimble Floppy)
Figure 4.112: Class 2 Device Recall Roadrunner Pc Wire Guide (The Firm)
Figure 4.113: Class 2 Device Recall Cook Roadrunner Uniglide Hydrophilic Wire Guide
Figure 4.114: Class 2 Device Recall Cook Roadrunner Pc Wire Guide
Figure 4.115: Class 2 Device Recall Roadrunner Hydrophilic Pc Wire Guide
Figure 4.116: Class 2 Device Recall Zurpaz(Tm) Medium Curl, Asymmetric Curve, Steerable Sheath
Figure 4.117: Class 2 Device Recall Ultimum Hemostasis Introducer
Figure 4.118: Class 2 Device Recall Fastcath Trio Hemostasis Introducer
Figure 4.119: Class 2 Device Recall Fastcath Hemostasis Introducer, Hemostasis Introducer
Figure 4.120: Class 2 Device Recall Avanti Catheter Sheath Introducer
Figure 4.121: Class 2 Device Recall
Figure 4.122: Class 2 Device Recall Flexor Checkflo Introducer
Figure 4.123: Class 1 Device Recall Flexor Checkflo Introducer
Figure 4.124: Class 2 Device Recall Hilal Embolization Microcoil
Figure 4.125: Class 2 Device Recall Nester Embolization Microcoil
Figure 4.126: Class 2 Device Recall Tornado Embolization Microcoil
Figure 4.127: Class 2 Device Recall Terumo Azur Peripheral Coil System, Detachable 18
Figure 4.128: Class 2 Device Recall Terumo Azur Cx Peripheral Coil System, Detachable 35, Cx Coil
Figure 4.129: Class 2 Device Recall Terumo Azur Cx Peripheral Coil System, Detachable 18, Cx Coil
Figure 4.130: Class 2 Device Recall Opticross 35 15 Mhz Peripheral Imaging Catheter
Figure 4.131: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion
Figure 4.132: Belgian Trial Investigating the Lifestream Stent in Complex Tasc C and D Iliac Lesions (Belstream)
Figure 4.133: Paclitaxel-Coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (Xpedite)
Figure 4.134: An All-Comers Observational Study of the Microstent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease (Heal)
Figure 4.135: Solaris Peripheral Pmcf Trial
Figure 4.136: a Superiority Trial of the Supera Peripheral Stent System in Patients With Femoro-Popliteal Artery Disease
Figure 4.137: Evaluation of Safety and Efficacy of the S.M.A.R.T. Radianz™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (Radiancy)
Figure 4.138: Stella Supera Siberia
Figure 4.139: a Real World Evaluation of the Eluvia Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (Regal)
Figure 4.140: Zilver® Ptx® V Clinical Study
Figure 4.141: In-Stent Restenosis Post-Approval Study
Figure 4.142: Bard® the Venovo™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (Vernacular)
Figure 4.143: Vivo Clinical Study
Figure 4.144: Ultrascore™ Focused Force Pta Balloon Angioplasty for Cli Patients With Below the Knee Vessel Disease
Figure 4.145: Real World Registry Assessing the Clinical Use of the Bard Ultrascore Forced Focus Pta Balloon
Figure 4.146: Ranger™ and Ranger™ Sl (Otw) Dcb in China
Figure 4.147: the Vasecure Btk Study
Figure 4.148: Comparison of the Ranger™ Paclitaxel-Coated Pta Balloon Catheter and Uncoated Pta Balloons in Femoropopliteal Arteries (Ranger-Sfa)
Figure 4.149: a Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-Coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic In.Pact Admiral Drug-Coated Balloon. (Biopact-Rct)
Figure 4.150: Safety and Efficacy of the Surveil™ Drug-Coated Balloon (Transcend)
Figure 4.151: Ranger™ Paclitaxel Coated Balloon Vs Standard Balloon Angioplasty (Ranger Ii Sfa)
Figure 4.152: In.Pact Btk Randomized Study to Assess Safety and Efficacy of In.Pact 014 Vs. Pta
Figure 4.153: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease
Figure 4.154: Illumenate Below-The-Knee (Btk) Arteries: a Post Market Clinical Study (Btk Pms)
Figure 4.155: In.Pact Global Clinical Study
Figure 4.156: Illumenate Pivotal Post-Approval Study (Pas)
Figure 4.157: Biolux P-Iii Benelux All-Comers Registry
Figure 4.158: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (Safe-Dcb)
Figure 4.159: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (Kaizen)
Figure 4.160: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the Sfa And/Or Ppa
Figure 4.161: Revascularization of Total or Sub-Total Occluded Peripheral Arteries With Bycross® Device. Post Market Clinical Follow-Up
Figure 4.162: Post-Market Registry of Auryon™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (Pathfinder-I)
Figure 4.163: Jet-Ranger Trial - Jetstream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty Vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon
Figure 4.164: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (Insight)
Figure 4.165: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for Pad Treatment
Figure 4.166: Safety and Effectiveness of Jetstream Atherectomy System (J-Supreme Ii)
Figure 4.167: Directional Atherectomy + Drug Coated Balloon to Treat Long, Calcified Femoropopliteal Artery Lesions (Reality)
Figure 4.168: Mini S Feasibility Study With Shockwave Medical Mini S Peripheral Ivl System
Figure 4.169: Solution Trial in China
Figure 4.170: Disrupt Pad+ Study With the Shockwave Medical M5+ Peripheral Ivl System (Disrupt Pad+)
Figure 4.171: Shockwave Medical Peripheral Lithoplasty System Study for Pad (Disrupt Pad Iii)
Figure 4.172: a Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (Panther)
Figure 4.173: Retrospective Post-Market Clinical Follow-Up Study of Gore-Tex® Vascular Grafts and Gore® Propaten® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
Figure 4.174: Ankura™ Taa Stent Graft System Post-Market Clinical Follow-Up Study
Figure 4.175: Post-Approval Study of the Treo Abdominal Stent-Graft System (Treo Pas)
Figure 4.176: the Merit Wrapsody™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
Figure 4.177: Zenith Alpha™ Abdominal Endovascular Graft
Figure 4.178: Fenestrated Aaa Endovascular Graft Post-Approval Study
Figure 4.179: Transshield Embolic Protection System Feasibility Study
Figure 4.180: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Figure 4.181: Preservation of Venous Valvular Function After Pmt for Acute Dvt (Prefer)
Figure 4.182: a Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System (Stride)
Figure 4.183: Flowtriever All-Comer Registry for Patient Safety and Hemodynamics (Flash)
Figure 4.184: Jeti Peripheral Thrombectomy Registry (Jeti)
Figure 4.185: Treatment of Low-Risk Submassive Pulmonary Embolism With Flowtriever
Figure 4.186: Forceps Vs. Snare Ivc Filter Removal
Figure 4.187: Predictors of Attempted Inferior Vena Cava Filters Retrieval
Figure 4.188: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
Figure 4.189: Cook Ivc Filter Study (Civc)
Figure 4.190: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (Preserve)
Figure 4.191: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F Vs Manual Compression (Reliaseal)
Figure 4.192: Absorbaseal (Abs 5.6.7) Vascular Closure Device Trial
Figure 4.193: Vascular Closure Device in Transcatheter Aortic Valve Replacement
Figure 4.195: Study to Evaluate the Safety and Effectiveness of Mynxgrip Vascular Closure Device (Panda)
Figure 4.196: (Halt) Embrace Hydrogel Embolic System (Hes) Study of Embolization in Peripheral Arterial Bleeds
Figure 4.197: Microvascular Plug (Mvp) for the Treatment of Pulmonary Arteriovenous Malformations (Pavms)
Figure 4.198: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization
Figure 4.199: Caterpillar™ Arterial Embolization Device Study (Chrysalis)
Figure 4.200: Lc Bead Lumi for Prostatic Artery Embolization
Figure 5.1: Currency Exchange Rate, 2022
Figure 5.2: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (€M) (1 of 3)
Figure 5.3: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (€M) (2 of 3)
Figure 5.4: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (€M) (3 of 3)
Figure 5.5: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (Us$M) (1 of 3)
Figure 5.6: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (Us$M) (2 of 3)
Figure 5.7: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (Us$M) (3 of 3)
Figure 5.8: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (1 of 4)
Figure 5.9: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (2 of 4)
Figure 5.10: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (3 of 4)
Figure 5.11: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (4 of 4)
Figure 5.12: SWOT Analysis, Abbott (1 of 2)
Figure 5.13: SWOT Analysis, Abbott (2 of 2)
Figure 5.14: SWOT Analysis, Becton Dickinson (1 of 2)
Figure 5.15: SWOT Analysis, Becton Dickinson (2 of 2)
Figure 5.16: SWOT Analysis, Boston Scientific
Figure 5.17: SWOT Analysis, Cardinal Health
Figure 5.18: SWOT Analysis, Cardiovascular Systems, Inc.
Figure 5.19: SWOT Analysis, Cook Medical
Figure 5.20: SWOT Analysis, Medtronic
Figure 5.21: SWOT Analysis, Penumbra
Figure 5.22: SWOT Analysis, Philips
Figure 5.23: SWOT Analysis, Shockwave Medical
Figure 5.24: SWOT Analysis, Silk Road Medical
Figure 5.25: SWOT Analysis, Terumo (1 of 2)
Figure 5.26: SWOT Analysis, Terumo (2 of 2)
Figure 5.27: SWOT Analysis, W.L. Gore
Figure 7.1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029 (1 of 3)
Figure 7.2: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029 (2 of 3)
Figure 7.3: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029 (3 of 3)
Figure 7.4: Peripheral Vascular Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.5: Arterial Stent Procedures by Device Type, Europe, 2019 - 2029
Figure 7.6: Arterial Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.7: Bare-Metal Stent Procedures by Indication, Europe, 2019 - 2029
Figure 7.8: Bare-Metal Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.9: Bare-Metal Carotid Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.10: Bare-Metal Iliac Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.11: Bare-Metal Renal Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.12: Bare-Metal Fem-Pop Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.13: Bare-Metal Infra-Pop Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.14: Covered Stent Procedures by Indication, Europe, 2019 - 2029
Figure 7.15: Covered Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.16: Iliac Covered Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.17: Fem-Pop Covered Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.18: Av Access Covered Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.19: Drug-Eluting Stent Procedures by Indication, Europe, 2019 - 2029
Figure 7.20: Drug-Eluting Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.21: Sfa Drug-Eluting Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.22: Infra-Pop Drug-Eluting Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.23: Venous Stent Procedures by Country, Europe, 2019 - 2029
Figure 7.24: Pta Balloon Catheter Procedures by Country, Europe, 2019 - 2029
Figure 7.25: Drug-Coated Balloon Procedures by Country, Europe, 2019 - 2029
Figure 7.26: Atherectomy Device Procedures by Device Type, Europe, 2019 - 2029
Figure 7.27: Atherectomy Device Procedures by Country, Europe, 2019 - 2029
Figure 7.28: Laser Atherectomy Device Procedures by Country, Europe, 2019 - 2029
Figure 7.29: Mechanical Atherectomy Device Procedures by Country, Europe, 2019 - 2029
Figure 7.30: Intravascular Lithotripsy Procedures by Device Type, Europe, 2019 - 2029
Figure 7.31: Intravascular Lithotripsy Procedures by Country, Europe, 2019 - 2029
Figure 7.32: Sfa and Iliac Lithotripsy Procedures by Country, Europe, 2019 - 2029
Figure 7.33: Btk Lithotripsy Procedures by Country, Europe, 2019 - 2029
Figure 7.34: Cto Device Procedures by Device Type, Europe, 2019 - 2029
Figure 7.35: Cto Device Procedures by Country, Europe, 2019 - 2029
Figure 7.36: Re-Entry Cto Procedures by Country, Europe, 2019 - 2029
Figure 7.37: Recanalization Cto Procedures by Country, Europe, 2019 - 2029
Figure 7.38: Total Surgical Graft Procedures by Material, Europe, 2019 - 2029
Figure 7.39: Total Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.40: Polyester Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.41: Eptfe Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.42: Total Surgical Graft Procedures by Indication, Europe, 2019 - 2029
Figure 7.43: Lower-Limb Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.44: Above-The-Knee Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.45: Below-The-Knee Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.46: Av Access Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.47: Aorta Repair Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.48: Abdominal Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.49: Thoracic Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.50: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.51: Stent Graft Procedures by Device Type, Europe, 2019 - 2029
Figure 7.52: Stent Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.53: Aaa Stent Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.54: Fenestrated Stent Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.55: Taa Stent Graft Procedures by Country, Europe, 2019 - 2029
Figure 7.56: Embolic Protection Device Procedures by Device Type, Europe, 2019 - 2029
Figure 7.57: Embolic Protection Device Procedures by Country, Europe, 2019 - 2029
Figure 7.58: Carotid Epd Procedures by Country, Europe, 2019 - 2029
Figure 7.59: Renal Epd Procedures by Country, Europe, 2019 - 2029
Figure 7.60: Lower-Limb Epd Procedures by Country, Europe, 2019 - 2029
Figure 7.61: Peripheral Thrombus Management Procedures by Device Type, Europe, 2019 - 2029
Figure 7.62: Peripheral Thrombus Management Procedures by Country, Europe, 2019 - 2029
Figure 7.63: Traditional Thrombectomy Device Procedures by Country, Europe, 2019 - 2029
Figure 7.64: Pharmacomechanical Thrombectomy Device Procedures by Country, Europe, 2019 - 2029
Figure 7.65 Ivcf Placement Procedures by Device Type, Europe, 2019 - 2029
Figure 7.66 Ivcf Placement Procedures by Country, Europe, 2019 - 2029
Figure 7.67: Retrievable Ivcf Procedures by Country, Europe, 2019 - 2029
Figure 7.68: Permanent Ivcf Procedures by Country, Europe, 2019 - 2029
Figure 7.69: Carotid Shunt Procedures by Country, Europe, 2019 - 2029
Figure 7.70: Total Vascular Closure Device Procedures by Device Type, Europe, 2019 - 2029
Figure 7.71: Total Vascular Closure Device Procedures by Country, Europe, 2019 - 2029
Figure 7.72: Small-Bore Invasive Vcd Procedures by Country, Europe, 2019 - 2029
Figure 7.73: Large-Bore Invasive Vcd Procedures by Country, Europe, 2019 - 2029
Figure 7.74: Non-Invasive Vcd Procedures by Country, Europe, 2019 - 2029
Figure 7.75: Total Vcd Procedures by Approach, Europe, 2019 - 2029
Figure 7.76: Radial Vcd Procedures by Country, Europe, 2019 - 2029
Figure 7.77: Femoral Vcd Procedures by Country, Europe, 2019 - 2029
Figure 7.78: Transcatheter Embolization Procedures by Device Type, Europe, 2019 - 2029
Figure 7.79: Transcatheter Embolization Procedures by Country, Europe, 2019 - 2029
Figure 7.80: Particle Embolization Procedures by Device Type, Europe, 2019 - 2029
Figure 7.81: Particle Embolization Procedures by Country, Europe, 2019 - 2029
Figure 7.82: Pva Particle Procedures by Country, Europe, 2019 - 2029
Figure 7.83: Microsphere Procedures by Country, Europe, 2019 - 2029
Figure 7.84: Drug-Eluting Particle Procedures by Country, Europe, 2019 - 2029
Figure 7.85: Radioactive Particle Procedures by Country, Europe, 2019 - 2029
Figure 7.86: Coil Embolization Procedures by Device Type, Europe, 2019 - 2029
Figure 7.87: Coil Embolization Procedures by Country, Europe, 2019 - 2029
Figure 7.88: Pushable Coil Procedures by Country, Europe, 2019 - 2029
Figure 7.89: Detachable Coil Procedures by Country, Europe, 2019 - 2029
Figure 7.90: Liquid Embolics Procedures by Country, Europe, 2019 - 2029
Figure 7.91: Plug Embolization Procedures by Country, Europe, 2019 - 2029
Figure 7.92: Peripheral Ivus Procedures by Country, Europe, 2019 - 2029
Figure 8.1: Peripheral Vascular Stent Market by Segment, Europe, 2019 - 2029 (€M)
Figure 8.2: Peripheral Vascular Stent Market by Segment, Europe, 2019 - 2029 (Us$M)
Figure 8.3: Arterial Stent Market by Device Type, Europe, 2019 - 2029 (€M)
Figure 8.4: Arterial Stent Market by Device Type, Europe, 2019 - 2029 (Us$M)
Figure 8.5: Arterial Stent Market, Europe, 2019 - 2029
Figure 8.6: Units Sold by Country, Arterial Stent Market, Europe, 2019 - 2029
Figure 8.7: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 - 2029 (€)
Figure 8.8: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.9: Market Value by Country, Arterial Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.10: Market Value by Country, Arterial Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.11: Bare-Metal Stent Market by Indication, Europe, 2019 - 2029 (€M)
Figure 8.12: Bare-Metal Stent Market by Indication, Europe, 2019 - 2029 (Us$M)
Figure 8.13: Total Bare-Metal Stent Market, Europe, 2019 - 2029
Figure 8.14: Units Sold by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029
Figure 8.15: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (€)
Figure 8.16: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.17: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.18: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.19: Bare-Metal Carotid Stent Market, Europe, 2019 - 2029
Figure 8.20: Units Sold by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029
Figure 8.21: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (€)
Figure 8.22: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.23: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.24: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.25: Bare-Metal Iliac Stent Market, Europe, 2019 - 2029
Figure 8.26: Units Sold by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029
Figure 8.27: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (€)
Figure 8.28: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.29: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.30: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.31: Bare-Metal Renal Stent Market, Europe, 2019 - 2029
Figure 8.32: Units Sold by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029
Figure 8.33: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (€)
Figure 8.34: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.35: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.36: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.37: Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029
Figure 8.38: Units Sold by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029
Figure 8.39: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (€)
Figure 8.40: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.41: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.42: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.43: Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029
Figure 8.44: Units Sold by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029
Figure 8.45: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (€)
Figure 8.46: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (Us$)
Figure 8.47: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (€M)
Figure 8.48: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (Us$M)
Figure 8.49: Covered Stent Market, Europe, 2019 - 2029
Figure 8.50: Units Sold by Country, Covered Stent Market, Europe, 2019 - 2029
Figure 8.51: Average Selling Price by Country, Covered Stent Market, Europe, 2019 - 2029 (€)
Figure 8.52: Average Selling Price by Country, Covered Stent Market, Europe, 2019 - 2029 (Us$)
